Health-Related Quality of Life Assessment And Communication During 48 Weeks Of Treatment Of Psoriasis Patients With Etanercept.

Trial Profile

Health-Related Quality of Life Assessment And Communication During 48 Weeks Of Treatment Of Psoriasis Patients With Etanercept.

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 22 Jun 2012

At a glance

  • Drugs Etanercept (Primary)
  • Indications Psoriasis
  • Focus Therapeutic Use
  • Most Recent Events

    • 22 Jun 2012 Actual initiation date (Oct 2008) added as reported by Netherlands Trial Register.
    • 22 Jun 2012 Planned end date changed from 30 Sep 2011 to 31 Dec 2012 as reported by Netherlands Trial Register.
    • 22 Jun 2012 Status changed from planning to recruiting as reported by Netherlands Trial Register.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top